+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cancer Supportive Care Market 2020-2024 - Product Image

Global Cancer Supportive Care Market 2020-2024

  • ID: 5005605
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Global Cancer Supportive Care Market 2020-2024.

The publisher has been monitoring the global cancer supportive care market 2020-2024 and it is poised to grow by USD 5.21 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the global cancer supportive care market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases. In addition, untapped potential in the developing countries is anticipated to boost the growth of the global cancer supportive care market 2020-2024 as well.

Market Segmentation

The publisher's global cancer supportive care market 2020-2024 is segmented as below:

Therapeutic Area:
  • Chemotherapy-induced Anemia
  • Chemotherapy-induced Neutropenia
  • Cancer Pain
  • CINV
  • Others
Geographic Segmentation:
  • North America
  • APAC
  • Europe
  • South America
  • MEA
Key Trends for global cancer supportive care market 2020-2024 growth

This study identifies untapped potential in the developing countries as the prime reasons driving the global cancer supportive care market 2020-2024 growth during the next few years.

Prominent vendors in global cancer supportive care Market 2020-2024.

The publisher provides a detailed analysis of around 25 vendors operating in the global cancer supportive care market 2020-2024, including some of the vendors such as Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Sanofi and Sun Pharmaceutical Industries Ltd. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Other 1
  • Market segments
  • Comparison by Other1 placement
  • Chemotherapy-induced anemia - Market size and forecast 2019-2024
  • Chemotherapy-induced neutropenia - Market size and forecast 2019-2024
  • Cancer pain - Market size and forecast 2019-2024
  • CINV - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Other1
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
  • Vendor Analysis
Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ billion)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Other1 placement - Market share 2019-2024 (%)
23. Comparison by Other1 placement
24. Chemotherapy-induced anemia - Market size and forecast 2019-2024 ($ billion)
25. Chemotherapy-induced anemia - Year-over-year growth 2019-2024 (%)
26. Chemotherapy-induced neutropenia - Market size and forecast 2019-2024 ($ billion)
27. Chemotherapy-induced neutropenia - Year-over-year growth 2019-2024 (%)
28. Cancer pain - Market size and forecast 2019-2024 ($ billion)
29. Cancer pain - Year-over-year growth 2019-2024 (%)
30. CINV - Market size and forecast 2019-2024 ($ billion)
31. CINV - Year-over-year growth 2019-2024 (%)
32. Others - Market size and forecast 2019-2024 ($ billion)
33. Others - Year-over-year growth 2019-2024 (%)
34. Market opportunity by Other1
35. Customer landscape
36. Market share by geography 2019-2024 (%)
37. Geographic comparison
38. North America - Market size and forecast 2019-2024 ($ billion)
39. North America - Year-over-year growth 2019-2024 (%)
40. Europe - Market size and forecast 2019-2024 ($ billion)
41. Europe - Year-over-year growth 2019-2024 (%)
42. APAC - Market size and forecast 2019-2024 ($ billion)
43. APAC - Year-over-year growth 2019-2024 (%)
44. South America - Market size and forecast 2019-2024 ($ billion)
45. South America - Year-over-year growth 2019-2024 (%)
46. MEA - Market size and forecast 2019-2024 ($ billion)
47. MEA - Year-over-year growth 2019-2024 (%)
48. Key leading countries
49. Market opportunity by geography ($ billion)
50. Impact of drivers and challenges
51. Vendor landscape
52. Landscape disruption
53. Industry risks
54. Vendors covered
55. Market positioning of vendors
56. Amgen Inc. - Overview
57. Amgen Inc. - Business segments
58. Amgen Inc. - Key offerings
59. Amgen Inc. - Key customers
60. Amgen Inc. - Segment focus
61. Baxter International Inc. - Overview
62. Baxter International Inc. - Product and service
63. Baxter International Inc. - Key offerings
64. Baxter International Inc. - Key customers
65. Baxter International Inc. - Segment focus
66. Bayer AG - Overview
67. Bayer AG - Business segments
68. Bayer AG - Key offerings
69. Bayer AG - Key customers
70. Bayer AG - Segment focus
71. Daiichi Sankyo Co. Ltd. - Overview
72. Daiichi Sankyo Co. Ltd. - Business segments
73. Daiichi Sankyo Co. Ltd. - Key offerings
74. Daiichi Sankyo Co. Ltd. - Key customers
75. Daiichi Sankyo Co. Ltd. - Segment focus
76. GlaxoSmithKline Plc - Overview
77. GlaxoSmithKline Plc - Business segments
78. GlaxoSmithKline Plc - Key offerings
79. GlaxoSmithKline Plc - Key customers
80. GlaxoSmithKline Plc - Segment focus
81. Johnson & Johnson - Overview
82. Johnson & Johnson - Business segments
83. Johnson & Johnson - Key offerings
84. Johnson & Johnson - Key customers
85. Johnson & Johnson - Segment focus
86. Merck & Co. Inc. - Overview
87. Merck & Co. Inc. - Business segments
88. Merck & Co. Inc. - Key offerings
89. Merck & Co. Inc. - Key customers
90. Merck & Co. Inc. - Segment focus
91. Novartis AG - Overview
92. Novartis AG - Business segments
93. Novartis AG - Key offerings
94. Novartis AG - Key customers
95. Novartis AG - Segment focus
96. Sanofi - Overview
97. Sanofi - Business segments
98. Sanofi - Key offerings
99. Sanofi - Key customers
100. Sanofi - Segment focus
101. Sun Pharmaceutical Industries Ltd. - Overview
102. Sun Pharmaceutical Industries Ltd. - Business segments
103. Sun Pharmaceutical Industries Ltd. - Key offerings
104. Sun Pharmaceutical Industries Ltd. - Key customers
105. Sun Pharmaceutical Industries Ltd. - Segment focus
106. Currency conversion rates for US$
107. Research Methodology
108. Validation techniques employed for market sizing
109. Information sources
110. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The publisher Announces the Publication of its Research Report-Global Cancer Supportive Care Market 2020-2024.

The publisher recognizes the following companies as the key players in the global cancer supportive care market: Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Sanofi and Sun Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the untapped potential in the developing countries."

According to the report, one of the major drivers for this market is the growing prevalence of cancer cases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Daiichi Sankyo Co. Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll